<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="case-report" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2025.1651275</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Urinary bladder paraganglioma presenting with abdominal pain and elevated cardiac enzymes: a case report of atypical manifestations and diagnostic challenges</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Zhou</surname><given-names>Hong</given-names></name>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1988579/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Hu</surname><given-names>Xiaohui</given-names></name>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yan</surname><given-names>Qin</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1267133/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><institution>Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University</institution>, <city>Shanghai</city>,&#xa0;<country country="cn">China</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Qin Yan, <email xlink:href="mailto:yanqin76@126.com">yanqin76@126.com</email></corresp>
<fn fn-type="equal" id="fn003">
<label>&#x2020;</label>
<p>These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-12-04">
<day>04</day>
<month>12</month>
<year>2025</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1651275</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>06</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>24</day>
<month>10</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Zhou, Hu and Yan.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Zhou, Hu and Yan</copyright-holder>
<license>
<ali:license_ref start_date="2025-12-04">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Urinary bladder paraganglioma (UBPGL) is a very rare neuroendocrine tumor, accounting for 0.05% of all bladder neoplasms. Classic symptoms include paroxysmal hypertension, palpitations, and sweating triggered by micturition. However, atypical presentations may complicate the diagnosis. This report describes the case of a 35-year-old woman who presented with persistent lower abdominal pain and isolated elevation of cardiac enzymes. Imaging revealed a pelvic mass initially suspected to be adnexal pathology. Emergency laparoscopy identified a retroperitoneal mass adjacent to the bladder and an endometriotic ovarian cyst. Postoperative pathology confirmed UBPGL, with immunohistochemistry positive for neuroendocrine markers (CD56, chromogranin-A, synaptophysin). Elevated cardiac enzymes and a prolonged QTc interval were observed preoperatively, likely secondary to catecholamine-induced myocardial injury, although biochemical confirmation was not available. The patient recovered uneventfully after resection of the tumor. This case highlights the potential for UBPGL to have atypical cardiovascular manifestations, including isolated elevation of cardiac enzymes without classic hypertensive crises. Such findings may reflect catecholamine-driven cardiomyocyte stress, emphasizing the need for heightened suspicion in cases that present with unexplained abdominal pain and cardiac abnormalities. Diagnostic challenges arise from overlapping symptoms with gynecologic emergencies and the rarity of preoperative biochemical testing in acute settings. UBPGL should be considered in patients with a pelvic mass accompanied by unexplained cardiac abnormalities. Early resection remains curative, but multidisciplinary evaluation, including biochemical screening for catecholamine excess, is critical to mitigate the cardiovascular risk. Long-term surveillance is warranted in view of the potential for metastasis. This case underscores the importance of including rare neuroendocrine tumors in the differential diagnoses for atypical abdominal presentations.</p>
</abstract>
<kwd-group>
<kwd>urinary bladder paraganglioma</kwd>
<kwd>cardiac enzymes</kwd>
<kwd>abdominal pain</kwd>
<kwd>case report</kwd>
<kwd>QTc</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declare that no financial support was received for the research and/or publication of this article.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="9"/>
<page-count count="6"/>
<word-count count="1706"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Genitourinary Oncology</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Paraganglioma is a rare neuroendocrine tumor originating from extra-adrenal neuroendocrine tissue, with approximately one third to half of cases located in the thoracoabdominal region (<xref ref-type="bibr" rid="B1">1</xref>).Urinary bladder paraganglioma (UBPGL), a subtype of paraganglioma, is exceedingly rare, arising from paraganglia within the bladder wall, and constitutes 0.7% of all paragangliomas and 0.05% of all bladder tumors (<xref ref-type="bibr" rid="B2">2</xref>). The rarity of UBPGL presents challenges in terms of clinical presentation, diagnosis, and management. Common clinical manifestations include paroxysmal hypertension, headache, palpitations, and sweating, which are typically triggered by micturition or bladder manipulation as a result of intermittent catecholamine release from the tumor (<xref ref-type="bibr" rid="B3">3</xref>). However, atypical manifestations can complicate the diagnostic process. This report describes a case of UBPGL that presented with abdominal pain and elevated cardiac enzymes and highlights the atypical clinical presentation, diagnostic challenges, and treatment of paragangliomas.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Case presentation</title>
<p>The patient was a 35-year-old married nulliparous woman with no history of chronic diseases or surgical procedures who presented with complaints of persistent lower abdominal pain and a sensation of rectal heaviness. Abdominal CT performed at another hospital revealed a low-density mass measuring 42&#xd7;80 mm in the right pelvic floor space, with increased edge density and clear boundaries. The patient visited our outpatient clinic with worsening abdominal pain. On presentation, she had a temperature of 36.5&#xa0;&#xb0;C, a blood pressure of 122/82 mmHg, a heart rate of 71 beats per minute, and an SpO<sub>2</sub> of 99%. Physical examination revealed significant abdominal tenderness and guarding, with equivocal rebound tenderness. A vaginal examination identified marked cervical tenderness, mild uterine tenderness, and a 6-cm mass in the right adnexal region with unclear boundaries and considerable tenderness. Ultrasonography revealed a hypoechoic area measuring 32&#xd7;34&#xd7;23 mm between the cervix and bladder, with clear boundaries, poor transmission, short linear hyperechoic structures inside, and sparse blood flow signals on the capsule; the right ovary showed a hypoechoic area measuring 42&#xd7;72&#xd7;64 mm (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>). Considering adnexal torsion or rupture as a potential cause of the patient&#x2019;s abdominal pain, she was admitted for emergency surgery. Her routine blood tests, coagulation profile, electrolytes level, liver and kidney function tests were normal on admission, and an electrocardiogram showed a heart rate of 80 beats per minute with a prolonged QTc interval and no ST-T segment changes (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2</bold></xref>). An emergency laparoscopy was performed, with a preoperative blood pressure of 145/95 mmHg, a heart rate of 90 beats per minute, and an SpO<sub>2</sub> of 99%. Intraoperatively, the right ovary was found to be enlarged, measuring 7&#xa0;cm in diameter, and to contain a cyst filled with chocolate-like fluid. There were no signs of cyst rupture or torsion of the ovary, and the cyst was excised (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3A</bold></xref>). A 4&#xd7;3&#xd7;2-cm mass behind the bladder and in front of the uterus was also identified and excised (<xref ref-type="fig" rid="f3"><bold>Figures&#xa0;3B&#x2013;D</bold></xref>). Both specimens were sent for pathological examination.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Transvaginal ultrasound showed a hypoechoic structure between the cervix and bladder, measuring 32X34X23mm <bold>(A, B)</bold>. and the right ovary showed hypoechoic areas measuring 42X72X64 mm <bold>(C, D)</bold>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1651275-g001.tif">
<alt-text content-type="machine-generated">Ultrasound images labeled A to D show different internal views with measurements indicated in millimeters. Image A displays dimensions of 32.1 and 22.9 mm. Image B has a measurement of 34.2 mm. Image C shows dimensions of 40.8 and 72.0 mm. Image D displays a measurement of 64.8 mm. The images capture varied textures and densities.</alt-text>
</graphic></fig>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>ECG showed prolonged QTc interval before operation and after operation; <bold>(A)</bold> before operation; <bold>(B)</bold> 2 hours after operation.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1651275-g002.tif">
<alt-text content-type="machine-generated">Electrocardiogram showing two panels labeled A and B. Each panel displays multiple leads, including V1, V2, V3, and V4, with distinct wave patterns. Both panels show different heart rhythms and wave formations on a grid, indicating changes in electrical activity.</alt-text>
</graphic></fig>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Intraoperative images. <bold>(A)</bold> the right ovary cast; <bold>(B&#x2013;D)</bold> the bladder Paraganglioma.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1651275-g003.tif">
<alt-text content-type="machine-generated">Four medical images labeled A to D, showcasing surgical views. Image A displays a large, white spherical mass within the abdominal cavity. Image B shows a smoother tissue area with visible veins and mild discoloration. Image C reveals a surgical incision showing layers of muscle and tissue. Image D depicts a deeper surgical site with tissues retracted to expose underlying structures.</alt-text>
</graphic></fig>
<p>The intraoperative laboratory report indicated that the cardiac enzyme profile had been abnormally elevated preoperatively, showed as followed: brain natriuretic peptide (BNP)694 pg/ml (reference range&lt;100 pg/ml), CTnI 3.918ng/ml ((reference range&lt;0.05ng/ml) and Creatine Kinase MB (CKMB)31 ng/ml (reference range &lt;0.5ng/ml) (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>). Immediately after surgery, rechecking of the cardiac enzyme profile showed that it was still elevated (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>), and the electrocardiogram again showed a prolonged QTc interval with no other abnormalities. Bedside echocardiography revealed an ejection fraction of 64%, normal cardiac chamber sizes, no organic changes in the valves, normal thickness and amplitude of the interventricular septum and left ventricular posterior wall, and mild tricuspid regurgitation. A CT scan showed scattered flocculent shadows in both lungs, with no other significant abnormalities. The patient was transferred to the intensive care unit for observation and treatment, and subsequent follow-up showed a gradual decrease in cardiac enzymes to the normal range. The patient recovered well, with a stable temperature, a heart rate of 65&#x2013;80 beats per minute, and blood pressure maintained at 58&#x2013;70/90&#x2013;115 mmHg. There were no complaints of discomfort, and she was discharged on the sixth postoperative day. <xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref> summarizes the patient&#x2019;s significant laboratory results.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Significant laboratory results and progress trends.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Summary of the patient's significant laboratory results</th>
<th valign="middle" align="left">Reference range</th>
<th valign="middle" align="left">Before-op</th>
<th valign="middle" align="left">Hour 1</th>
<th valign="middle" align="left">Hour 6</th>
<th valign="middle" align="left">Day1</th>
<th valign="middle" align="left">Day2</th>
<th valign="middle" align="left">Day4</th>
<th valign="middle" align="left">Day6</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">WBC (10^9/L)</td>
<td valign="middle" align="left">3.5-9.5</td>
<td valign="middle" align="left">14.5</td>
<td valign="middle" align="left">13.07</td>
<td valign="middle" align="left">14.19</td>
<td valign="middle" align="left">7.90</td>
<td valign="middle" align="left">6.66</td>
<td valign="middle" align="left">5.39</td>
<td valign="middle" align="left">4.97</td>
</tr>
<tr>
<td valign="middle" align="left">HB (g/L)</td>
<td valign="middle" align="left">115-150</td>
<td valign="middle" align="left">114</td>
<td valign="middle" align="left">99</td>
<td valign="middle" align="left">91</td>
<td valign="middle" align="left">79</td>
<td valign="middle" align="left">76</td>
<td valign="middle" align="left">78</td>
<td valign="middle" align="left">90</td>
</tr>
<tr>
<td valign="middle" align="left">PLT (10^9/L)</td>
<td valign="middle" align="left">125-350</td>
<td valign="middle" align="left">491</td>
<td valign="middle" align="left">387</td>
<td valign="middle" align="left">334</td>
<td valign="middle" align="left">244</td>
<td valign="middle" align="left">247</td>
<td valign="middle" align="left">282</td>
<td valign="middle" align="left">354</td>
</tr>
<tr>
<td valign="middle" align="left">D-dimer (mg/L)</td>
<td valign="middle" align="left">&lt;0.55</td>
<td valign="middle" align="left">3.42</td>
<td valign="middle" align="left">3.14</td>
<td valign="middle" align="left">3.80</td>
<td valign="middle" align="left">1.29</td>
<td valign="middle" align="left">1.2</td>
<td valign="middle" align="left">1.13</td>
<td valign="middle" align="left">1.48</td>
</tr>
<tr>
<td valign="middle" align="left">BNP (pg/ml)</td>
<td valign="middle" align="left">&lt;100</td>
<td valign="middle" align="left">694</td>
<td valign="middle" align="left">762</td>
<td valign="middle" align="left">945</td>
<td valign="middle" align="left">349</td>
<td valign="middle" align="left">90.2</td>
<td valign="middle" align="left">119</td>
<td valign="middle" align="left">75.4</td>
</tr>
<tr>
<td valign="middle" align="left">CTnI (ng/ml)</td>
<td valign="middle" align="left">&lt;0.05</td>
<td valign="middle" align="left">3.918</td>
<td valign="middle" align="left">3.355</td>
<td valign="middle" align="left">2.083</td>
<td valign="middle" align="left">0.96</td>
<td valign="middle" align="left">0.42</td>
<td valign="middle" align="left">0.07</td>
<td valign="middle" align="left">&lt;0.05</td>
</tr>
<tr>
<td valign="middle" align="left">CKMB (ng/ml)</td>
<td valign="middle" align="left">&lt;5</td>
<td valign="middle" align="left">41</td>
<td valign="middle" align="left">33.3</td>
<td valign="middle" align="left">20.5</td>
<td valign="middle" align="left">4.4</td>
<td valign="middle" align="left">&lt;1</td>
<td valign="middle" align="left">&lt;1</td>
<td valign="middle" align="left">&lt;1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>WBC, white blood cell; HB, hemoglobin; PLT, platelet; BNP, brain natriuretic peptide; CTnl, cardiac troponin1; CKMB, Creatine Kinase MB.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The postoperative pathological diagnosis was retroperitoneal paraganglioma of the bladder and endometrial cyst in the right ovary. Hematoxylin&#x2013;eosin staining of the bladder paraganglioma showed characteristic nests of cells (known as the Zellballen pattern) with eosinophilic cytoplasm and round nuclei. CD56, chromogranin-A, synaptophysin, and vimentin staining was strongly positive. In contrast, S100 staining was positive in patches, and staining for pancytokeratin and epithelial membrane antigen was negative (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4</bold></xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>HE and Immunohistochemical staining of tumor cells. <bold>(A)</bold> 200x magnification of HE staining showed Zellballen pattern; <bold>(B&#x2013;E)</bold> Diffuse and strongly positive for CD56 <bold>(B)</bold>, Chromogranin-A <bold>(C)</bold>, Synaptophysin <bold>(D)</bold>, Vimentin <bold>(E)</bold> Immunohistochemistry; <bold>(F)</bold> less positive for S100 Immunohistochemistry; <bold>(G, H)</bold> negative for CKpan <bold>(G)</bold> and EMA <bold>(H)</bold> Immunohistochemistry. HE, Hematoxylin and Eosin.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1651275-g004.tif">
<alt-text content-type="machine-generated">Microscopic images of tissue samples labeled A to H show various staining techniques. Image A displays a hematoxylin and eosin stain with a pink and purple hue. Images B to E display strong brown staining indicative of different markers. Images F to H show less intense staining with lighter tones, indicating weaker marker expression. Each image depicts cellular structures and patterns relevant to pathological examination.</alt-text>
</graphic></fig>
</sec>
<sec id="s3" sec-type="discussion">
<label>3</label>
<title>Discussion</title>
<p>This case highlights the atypical clinical manifestations and diagnostic challenges associated with paragangliomas. Although our patient had a concurrent endometriotic ovarian cyst, intraoperative laparoscopic examination did not reveal any signs of rupture or torsion. Therefore, the patient&#x2019;s abdominal pain was unlikely to be related to the cyst. Her abdominal pain was eventually linked to a paraganglioma, and the preoperative elevation of cardiac enzymes may have been related to the cardiac effects of catecholamines secreted by the tumor. However, this case was treated as a surgical emergency, so paraganglioma was not considered preoperatively, and the patient had been discharged by the time the pathological diagnosis was confirmed. And during the subsequent follow-up, the patient refused to undergo genetic testing.</p>
<p>Paraganglioma is a rare tumor originating from cells of the neural&#xa0;crest. Its most common clinical manifestations include paroxysmal hypertension, headaches, palpitations, and sweating, usually triggered&#xa0;by urination or manipulation of the bladder (<xref ref-type="bibr" rid="B4">4</xref>). These symptoms are attributed to the intermittent release of catecholamines&#xa0;by the tumor.&#xa0;However, atypical presentations may occur, further&#xa0;complicating the diagnostic process. Patients rarely present with cardiac complications initially. Paraganglioma-induced cardiomyopathy occurs in up to 11% of cases; it is commonly associated with adrenal pheochromocytoma (90%) and rarely with paragangliomas originating from the sympathetic ganglia (10%). The cardiovascular complications of paraganglioma are diverse, and paraganglioma-related cardiomyopathy can be chronic or acute, with Takotsubo cardiomyopathy being the most frequently reported. Presentations with abnormal myocardial enzyme levels alone are rare (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). Moreover, the infrequent occurrence of atypical preoperative presentations poses a significant diagnostic dilemma for urologists (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>In conclusion, early diagnosis and treatment of paraganglioma is essential, given the potential for this tumor to result in severe cardiovascular complications. Correct diagnosis and treatment can significantly improve the prognosis. This case report underscores the importance of careful evaluation of patients with abdominal pain and elevation of cardiac enzymes, as well as the need to consider rare conditions, such as paraganglioma, in the diagnostic process. Physicians need to be vigilant, maintaining a high index of clinical suspicion for prompt and effective treatment, even in cases of patient-reported symptoms or atypical differential diagnoses (or rare coexistences). Even in cases of negative lab and imaging workup, a small lesion can be hidden in the bladder. Surgical resection remains the only effective treatment for paraganglioma, involving partial or complete cystectomy, some reports recommended transurethral resection of bladder tumor (TURBT) (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). Long-term clinical follow-up include genetic background analysis such as SDHB, SDHD, VHL, and RET, required in view of the metastatic potential of this rare neuroendocrine tumor.</p>
</sec>
</body>
<back>
<sec id="s4" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p></sec>
<sec id="s5" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article. Written informed consent was obtained from the participant/patient(s) for the publication of this case report.</p></sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>HZ: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. QY: Resources, Supervision, Validation, Writing &#x2013; review &amp; editing. XH: Data curation, Methodology, Writing &#x2013; original draft.</p></sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s9" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors&#xa0;and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Symeonidis</surname> <given-names>EN</given-names></name>
<name><surname>Symeonidis</surname> <given-names>A</given-names></name>
<name><surname>Gkekas</surname> <given-names>C</given-names></name>
<name><surname>Georgiadis</surname> <given-names>C</given-names></name>
<name><surname>Malioris</surname> <given-names>A</given-names></name>
<name><surname>Papathanasiou</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Urothelial neoplasm in a 19-year-old male patient with urine discoloration, negative lab, and imaging workup: Should we investigate the findings or the symptom</article-title>? <source>Clin Case Rep</source>. (<year>2019</year>) <volume>7</volume>:<page-range>409&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ccr3.1909</pub-id>, PMID: <pub-id pub-id-type="pmid">30899460</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kouba</surname> <given-names>E</given-names></name>
<name><surname>Cheng</surname> <given-names>L</given-names></name>
</person-group>. 
<article-title>Neuroendocrine tumors of the urinary bladder according to the 2016 world health organization classification: molecular and clinical characteristics</article-title>. <source>Endocr Pathol</source>. (<year>2016</year>) <volume>27</volume>:<page-range>188&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12022-016-9444-5</pub-id>, PMID: <pub-id pub-id-type="pmid">27334654</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname> <given-names>K</given-names></name>
<name><surname>Ebbehoj</surname> <given-names>AL</given-names></name>
<name><surname>Obeid</surname> <given-names>H</given-names></name>
<name><surname>Vaidya</surname> <given-names>A</given-names></name>
<name><surname>Else</surname> <given-names>T</given-names></name>
<name><surname>Wachtel</surname> <given-names>H</given-names></name>
<etal/>
</person-group>. 
<article-title>Presentation, management, and outcomes of urinary bladder paraganglioma: results from a multicenter study</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2022</year>) <volume>107</volume>:<page-range>2811&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/clinem/dgac427</pub-id>, PMID: <pub-id pub-id-type="pmid">35882219</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mete</surname> <given-names>O</given-names></name>
<name><surname>Asa</surname> <given-names>SL</given-names></name>
<name><surname>Gill</surname> <given-names>AJ</given-names></name>
<name><surname>Kimura</surname> <given-names>N</given-names></name>
<name><surname>de Krijger</surname> <given-names>RR</given-names></name>
<name><surname>Tischler</surname> <given-names>A</given-names></name>
</person-group>. 
<article-title>Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas</article-title>. <source>Endocr Pathol</source>. (<year>2022</year>) <volume>33</volume>:<fpage>90</fpage>&#x2013;<lpage>114</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12022-022-09704-6</pub-id>, PMID: <pub-id pub-id-type="pmid">35285002</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Petrak</surname> <given-names>O</given-names></name>
<name><surname>Kratka</surname> <given-names>Z</given-names></name>
<name><surname>Holaj</surname> <given-names>R</given-names></name>
<name><surname>Zitek</surname> <given-names>M</given-names></name>
<name><surname>Nguyen Nikrynova</surname> <given-names>T</given-names></name>
<name><surname>Klimova</surname> <given-names>J</given-names></name>
<etal/>
</person-group>. 
<article-title>Cardiovascular complications in pheochromocytoma and paraganglioma: does phenotype matter</article-title>? <source>Hypertension</source>. (<year>2024</year>) <volume>81</volume>:<fpage>595</fpage>&#x2013;<lpage>603</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.123.21902</pub-id>, PMID: <pub-id pub-id-type="pmid">38152977</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Szatko</surname> <given-names>A</given-names></name>
<name><surname>Glinicki</surname> <given-names>P</given-names></name>
<name><surname>Gietka-Czernel</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Pheochromocytoma/paraganglioma-associated cardiomyopathy</article-title>. <source>Front Endocrinol (Lausanne)</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1204851</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2023.1204851</pub-id>, PMID: <pub-id pub-id-type="pmid">37522121</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Symeonidis</surname> <given-names>A</given-names></name>
<name><surname>Tsikopoulos</surname> <given-names>I</given-names></name>
<name><surname>Symeonidis</surname> <given-names>EN</given-names></name>
<name><surname>Tsifountoudis</surname> <given-names>I</given-names></name>
<name><surname>Michailidis</surname> <given-names>A</given-names></name>
<name><surname>Tsantila</surname> <given-names>I</given-names></name>
<etal/>
</person-group>. 
<article-title>More than meets the eye: A case of synchronous ipsilateral clear cell renal cell carcinoma and urothelial carcinoma of the pelvicalyceal system and literature review</article-title>. <source>Acta Biomed</source>. (<year>2022</year>) <volume>92</volume>:<fpage>e2021380</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.23750/abm.v92i6.11768</pub-id>, PMID: <pub-id pub-id-type="pmid">35075075</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Symeonidis</surname> <given-names>EN</given-names></name>
<name><surname>Lo</surname> <given-names>KL</given-names></name>
<name><surname>Chui</surname> <given-names>KL</given-names></name>
<name><surname>Vakalopoulos</surname> <given-names>I</given-names></name>
<name><surname>Sountoulides</surname> <given-names>P</given-names></name>
</person-group>. 
<article-title>En bloc resection of bladder tumors: challenges and unmet needs in 2022</article-title>. <source>Future Oncol</source>. (<year>2022</year>) <volume>18</volume>:<page-range>2545&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2217/fon-2021-1228</pub-id>, PMID: <pub-id pub-id-type="pmid">35642479</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Matsumoto</surname> <given-names>S</given-names></name>
<name><surname>Ishikawa</surname> <given-names>Y</given-names></name>
<name><surname>Fukushima</surname> <given-names>H</given-names></name>
<name><surname>Yamamoto</surname> <given-names>K</given-names></name>
<name><surname>Tsujimoto</surname> <given-names>K</given-names></name>
<name><surname>Kimura</surname> <given-names>K</given-names></name>
<etal/>
</person-group>. 
<article-title>A case of bladder paraganglioma completely resected by transurethral endoscopic en-bloc resection of bladder tumor</article-title>. <source>IJU Case Rep</source>. (<year>2025</year>) <volume>8</volume>:<page-range>93&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/iju5.12811</pub-id>, PMID: <pub-id pub-id-type="pmid">40034905</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1596545">Sergei Tevosian</ext-link>, University of Florida, United States</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1711163">Evangelos N. Symeonidis</ext-link>, European Interbalkan Medical Center, Greece</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1088112">Aleksandra Gilis-Januszewska</ext-link>, Jagiellonian University Medical College, Poland</p></fn>
</fn-group>
</back>
</article>